Bulletin
Investor Alert

VBI Vaccines Inc.

NAS: VBIV

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jun 11, 2021, 7:53 p.m.

/zigman2/quotes/201705917/composite

$

3.95

Change

+0.01 +0.25%

Volume

Volume 39,750

Quotes are delayed by 20 min

/zigman2/quotes/201705917/composite

Previous close

$ 4.11

$ 3.94

Change

-0.17 -4.14%

Day low

Day high

$3.88

$4.14

Open

52 week low

52 week high

$2.06

$6.93

Open

Annual Financials for VBI Vaccines Inc.

Operating Activities

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Net Income before Extraordinaries (23.21M)(39M)(63.6M)(54.81M)(46.23M)
Depreciation, Depletion & Amortization 606,000730,000542,0001.2M1.65M
Depreciation and Depletion 540,000667,000481,0001.14M1.59M
Amortization of Intangible Assets 66,00063,00061,00062,00064,000
Deferred Taxes & Investment Tax Credit (1.78M)(431,000)---
Deferred Taxes (1.78M)(431,000)---
Investment Tax Credit -----
Other Funds 2.97M4.11M5.05M11.53M7.67M
Funds from Operations (21.41M)(34.59M)(58.01M)(42.08M)(36.91M)
Extraordinaries -----
Changes in Working Capital 2.89M3.21M12.47M(6.63M)(9.16M)
Receivables 113,000(127,000)79,000(136,000)130,000
Accounts Payable 11,000(675,000)3.8M(5.18M)2.06M
Other Assets/Liabilities 2.86M4.1M8.97M(932,000)(9.4M)
Net Operating Cash Flow (18.52M)(31.38M)(45.53M)(48.71M)(46.07M)

Investing Activities

20162017201820192020 5-year trend
Capital Expenditures (585,000)(640,000)(5.99M)(3.67M)(1M)
Capital Expenditures (Fixed Assets) (585,000)(640,000)(5.99M)(3.67M)(1M)
Capital Expenditures (Other Assets) -----
Net Assets from Acquisitions -----
Sale of Fixed Assets & Businesses 2.13M----
Purchase/Sale of Investments ----(25M)
Purchase of Investments ----(25M)
Sale/Maturity of Investments -----
Other Uses (41,000)----
Other Sources -61,000---
Net Investing Cash Flow 1.5M(579,000)(5.99M)(3.67M)(26M)

Financing Activities

20162017201820192020 5-year trend
Cash Dividends Paid - Total -----
Common Dividends -----
Preferred Dividends -----
Change in Capital Stock 37.01M67.24M43.62M37.42M118.71M
Repurchase of Common & Preferred Stk. -(4.68M)---
Sale of Common & Preferred Stock 37.01M71.92M43.62M37.42M118.71M
Proceeds from Stock Options 24.17M71.91M43.55M37.42M116.57M
Other Proceeds from Sale of Stock 12.84M16,00065,000-2.14M
Issuance/Reduction of Debt, Net (525,000)---2.7M
Change in Current Debt ----(978,000)
Change in Long-Term Debt (525,000)---3.68M
Issuance of Long-Term Debt ----18.98M
Reduction in Long-Term Debt (525,000)---(15.3M)
Other Funds -----
Other Uses -----
Other Sources -----
Net Financing Cash Flow 36.48M67.24M43.62M37.42M121.41M
Exchange Rate Effect 340,000132,000(515,000)(87,000)270,000
Miscellaneous Funds -----
Net Change in Cash 19.81M35.41M(8.42M)(15.06M)49.61M
Free Cash Flow (19.1M)(32.02M)(51.53M)(52.39M)(47.07M)
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.